Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen...
98 insider purchases on record · latest filing 2026-09-30.
Insiders have also filed 1 sale transaction at ANIX.